---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-26-004645"
form_type: "8-K"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2026-09-29T14:31:04+00:00"
generated_at: "2026-10-12T13:45:24.757963+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Silexion Therapeutics reprices series E warrants to $0.2603, expects about $0.84M gross proceeds

## Summary
- Silexion Therapeutics entered a Sept 28, 2026 inducement letter with holders of 3,216,928 series E warrants to exercise at a reduced $0.2603/share price.
- The warrant exercise is expected to raise about $0.84 million gross, before H.C. Wainwright fees; closing is expected on or about Sept 29, 2026.
- Silexion will issue Series F and Series G warrants for up to 6,433,856 ordinary shares at $0.2603/share; Series F lasts five years, Series G 24 months after conditions.
- H.C. Wainwright & Co. is exclusive placement agent, earning a 7.0% cash fee, 1.0% management fee, and up to 225,185 placement agent warrants at $0.3254/share.
- Silexion also cut the exercise price for all outstanding series E warrants covering 3,846,161 ordinary shares to $0.2603/share.

## SEC filing metadata
- accession: 0001178913-26-004645
- form_type: 8-K
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2026-09-29T14:31:04+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000117891326004645/0001178913-26-004645-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000117891326004645/zk2636167.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-26-004645
- JSON: https://secwatch.observer/filing/0001178913-26-004645.json
- Plain text: https://secwatch.observer/filing/0001178913-26-004645.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.